Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr Joseba Rebollo Liceaga posiada ponad 30-letnie doświadczenie w dziedzinie onkologii, specjalizując się w multidyscyplinarnych metodach leczenia.

• Kieruje oddziałami onkologii w wielu prestiżowych szpitalach
• Jest autorem badań naukowych nad elektrochemioterapią
• Specjalista onkologii klinicznej w Clínica Universidad de Navarra
• Obecnie praktykuje w Quirónsalud Alicante

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Specjalizuje się w złożonych operacjach onkologicznych, w tym w zabiegach trzustki i dróg żółciowych w szpitalach Büyük Anadolu.

• Posiada wiedzę ekspercką w chirurgii onkologicznej, ze szczególnym uwzględnieniem nowotworów układu pokarmowego
• Wykonuje zaawansowane operacje raka piersi i tarczycy
• Biegle posługuje się technikami chirurgii bariatrycznej i metabolicznej

Specjalizowała się w onkologii radiacyjnej na Uniwersytecie Marmara — jednej z czołowych uczelni medycznych w Turcji.

• Ukończyła Wydział Lekarski Uniwersytetu Marmara
• Odbyła specjalistyczne szkolenie w zakresie onkologii radiacyjnej
• Pracuje w Szpitalu Emsey — wiodącym ośrodku leczenia nowotworów

Kierownik ds. szkoleń w Szpitalu Regionalnym w Puerto Vallarta, posiada bogate doświadczenie w procedurach małoinwazyjnych oraz zabiegach laserowych.

• Ponad 8 lat praktyki jako lekarz ogólny w gabinecie prywatnym
• Specjalizuje się w zabiegach dermatologicznych i kosmetologicznych
• Przeszkolony w zakresie biomagnetyzmu przez Isaaca Goiza Durana
• Doświadczony w stosowaniu kawitacji ultradźwiękowej oraz fototerapii światłem UV

Dr Raj wykonał ponad 50 000 operacji onkologicznych w ciągu 19 lat praktyki. Specjalizuje się w chirurgii onkologicznej piersi i klatki piersiowej w HCG Manavata Cancer Centre.

• Kształcił się w Tata Memorial Hospital oraz Royal College of Surgeons w Edynburgu
• Uczestniczy w ponad 200 badaniach klinicznych, w tym w badaniach fazy 1-3
• Jest profesorem w ramach super-specjalizacji DNB z chirurgii onkologicznej oraz chirurgii piersi
• Koncentruje się na poprawie jakości życia pacjentów równolegle z prowadzonym leczeniem

Dr Shruti Kate specjalizuje się w zaawansowanych metodach leczenia nowotworów, w tym w immunoterapii i terapii metronomicznej. Wiedzę zdobywała w Tata Memorial Hospital – wiodącym ośrodku onkologicznym w Indiach.

• Ekspert w zakresie raka płuc, piersi oraz nowotworów ginekologicznych
• Członek ASCO, ESMO oraz innych prestiżowych towarzystw onkologicznych
• Prezentowała badania nad rakiem płuca na Światowej Konferencji Raka Płuca
• Stosuje innowacyjne podejścia w przypadkach zaawansowanych nowotworów